Activity 1

Development and optimization of innovative techniques and methods that allow the assurance of post-marketing quality of medicines used by the population for the treatment and prevention of AIDS and NTD, according to international standards.

Activity 2

Design of sampling plans at the critical points of distribution and dispensing of medicines and surveillance studies that allow the evaluation of the health risk involved in the consumption of substandard drugs.

Activity 3

Transfer of the results obtained in R&D to support the WHO prequalification for the LNCQM.